A randomized and controlled Phase 1 study of the safety and immunogenicity of the AMA1-C1/Alhydrogel® +CPG 7909 vaccine for Plasmodium falciparum malaria in semi-immune Malian adults
Titel:
A randomized and controlled Phase 1 study of the safety and immunogenicity of the AMA1-C1/Alhydrogel® +CPG 7909 vaccine for Plasmodium falciparum malaria in semi-immune Malian adults
Auteur:
Sagara, Issaka Ellis, Ruth D. Dicko, Alassane Niambele, Mohamed B. Kamate, Beh Guindo, Ousmane Sissoko, Mahamadou S. Fay, Michael P. Guindo, Merepen A. Kante, Ousmane Saye, Renion Miura, Kazutoyo Long, Carole Mullen, Gregory E.D. Pierce, Mark Martin, Laura B. Rausch, Kelly Dolo, Amagana Diallo, Dapa A. Miller, Louis H. Doumbo, Ogobara K.